Predictive Analysis of Amyotrophic Lateral Sclerosis Progression and Mortality in a Clinic Cohort From Singapore
Muscle & Nerve · 2025
DOI: 10.1002/mus.28416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Ian Qian Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Duke-NUS Medical School, Singapore. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agency for Science, Technology and Research, National Neuroscience Institute.
Abstract (Originalsprache)
Introduction
There is currently no comprehensive Amyotrophic Lateral Sclerosis (ALS) patient database in Singapore comparable to those available in Europe and the United States. We established the Singapore ALS registry (SingALS) to draw meaningful inferences about the ALS population in Singapore through developing statistical and machine learning‐based predictive models.
Methods
The SingALS registry was established through the retrospective collection of demographic, clinical, and laboratory data from 72 ALS patients at Tan Tock Seng Hospital (TTSH) and combining it with demographic and clinical data from 71 patients at Singapore General Hospital (SGH). The SingALS was compared against international ALS registries. Using comparative studies including survival and temporal feature analysis, we identified key factors influencing ALS survival and developed a machine learning model to predict survival outcomes.
Results
Compared to Caucasian‐dominant registries, such as the German Swabia registry, SingALS patients had longer average survival (50.51 vs. 31.0 months), younger age of onset (56.18 vs. 66.6 years), and lower bulbar onset prevalence (20.98% vs. 34.10%). Singaporean males had poorer outcomes compared to females, with a hazard ratio (HR) of 3.12 ( p = 0.008). Patients who died within 24 months had an earlier need for being bedbound ( p < 0.004), percutaneous endoscopic gastrostomy (PEG) insertion ( p = 0.004) and non‐invasive ventilation (NIV) ( p < 0.001). Machine learning and statistical analysis indicated that a steeper ALSFRS‐R slope, higher alkaline phosphatase (ALP), white blood cell (WBC), absolute neutrophil counts, and creatinine levels are associated with worse mortality.
Discussion
We developed a comprehensive Singaporean ALS registry and identified key factors influencing survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke-NUS Medical School, Singapore.
- National Neuroscience Institute, Singapore.
- Institute for Infocomm Research (I2R), A*STAR, Singapore.
- Centre for Quantitative Medicine, Duke-NUS, Singapore.
- Department of Neurology, Pennsylvania State University, Hershey, Pennsylvania, USA.
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.
ORCID-Profile: Ian Qian Xu, Ling Guo, Crystal Jing Jing Yeo
Förderung
- Agency for Science, Technology and Research
- National Neuroscience Institute
Zitieren
APA
Xu, I. Q., Guo, L., Xu, J., Setiawan, S., Deng, X., Lo, Y. L., Chai, J. Y. H., Simmons, Z., Ramasamy, S., & Yeo, C. J. J. (2025). Predictive Analysis of Amyotrophic Lateral Sclerosis Progression and Mortality in a Clinic Cohort From Singapore. Muscle & Nerve. https://doi.org/10.1002/mus.28416
Vancouver
Xu IQ, Guo L, Xu J, Setiawan S, Deng X, Lo YL, et al. Predictive Analysis of Amyotrophic Lateral Sclerosis Progression and Mortality in a Clinic Cohort From Singapore. Muscle & Nerve. 2025. doi:10.1002/mus.28416
BibTeX
@article{Xu2025,
author = {Xu, Ian Qian and Guo, Ling and Xu, Jing and Setiawan, Stella and Deng, Xiao and Lo, Yew Long and Chai, Josiah Yui Huei and Simmons, Zachary and Ramasamy, Savitha and Yeo, Crystal Jing Jing},
title = {Predictive Analysis of Amyotrophic Lateral Sclerosis Progression and Mortality in a Clinic Cohort From Singapore},
journal = {Muscle & Nerve},
year = {2025},
doi = {10.1002/mus.28416}
}
EUVIMED